China Shineway Pharmaceutical Group Ltd
HKEX:2877
Intrinsic Value
The intrinsic value of one China Shineway Pharmaceutical Group Ltd stock under the Base Case scenario is 20.69 HKD. Compared to the current market price of 7.62 HKD, China Shineway Pharmaceutical Group Ltd is Undervalued by 63%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
China Shineway Pharmaceutical Group Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
China Shineway Pharmaceutical Group Ltd
Balance Sheet Decomposition
China Shineway Pharmaceutical Group Ltd
Current Assets | 8.6B |
Cash & Short-Term Investments | 6.5B |
Receivables | 1.2B |
Other Current Assets | 906.5m |
Non-Current Assets | 1.4B |
PP&E | 1.2B |
Intangibles | 189.3m |
Other Non-Current Assets | 34.3m |
Free Cash Flow Analysis
China Shineway Pharmaceutical Group Ltd
CNY | |
Free Cash Flow | CNY |
Earnings Waterfall
China Shineway Pharmaceutical Group Ltd
Revenue
|
3.8B
CNY
|
Cost of Revenue
|
-946.3m
CNY
|
Gross Profit
|
2.8B
CNY
|
Operating Expenses
|
-1.8B
CNY
|
Operating Income
|
1B
CNY
|
Other Expenses
|
-173.9m
CNY
|
Net Income
|
840.1m
CNY
|
Profitability Score
Profitability Due Diligence
China Shineway Pharmaceutical Group Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Score
China Shineway Pharmaceutical Group Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Shineway Pharmaceutical Group Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Score
China Shineway Pharmaceutical Group Ltd's solvency score is 92/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China Shineway Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for China Shineway Pharmaceutical Group Ltd is 12.41 HKD with a low forecast of 8.59 HKD and a high forecast of 18.9 HKD.
Dividends
Current shareholder yield for China Shineway Pharmaceutical Group Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one China Shineway Pharmaceutical Group Ltd stock under the Base Case scenario is 20.69 HKD.
Compared to the current market price of 7.62 HKD, China Shineway Pharmaceutical Group Ltd is Undervalued by 63%.